Brian McNamara

Mr. McNamara has served as Chief Executive Officer of Haleon plc ((formerly GSK ConsumerHealthcare), a global consumer healthcare company, since May 2022. Mr. McNamara joined GlaxoSmithKline plc, a global pharmaceutical and biotechnology company, in 2015 and served in various capacities, including Chief Executive Officer Designate, Haleon, from July 2021 to May 2022, Chief Executive Officer, GSK Consumer Healthcare from October 2016 to May 2021 and Head of Europe and Americas, GSK Consumer Healthcare from March 2015 to September 2016. Prior to that, he worked for 28 years in a variety of leadership positions for several global consumer products providers, including Novartis AG and The Procter & Gamble Company. Mr. McNamara serves of the Board of Directors of Haleon plc.

DIRECTOR QUALIFICATIONS:

• During his 36-year career, Mr. McNamara gained valuable experience in executive leadership, global operations management. He has a strong track record of building and marketing global brands, including driving strong, profitable growth and brand innovation.
• Mr. McNamara brings strong consumer products industry knowledge and marketing experience from his work at GSK Consumer Healthcare, Novartis AG and The Procter & Gamble Company. He brings a global perspective to the Board, having lived and worked in Europe and the Americas.
• Mr. McNamara has public company board and corporate governance experience. He is a director of Haleon plc.